The widely held view that sperm counts in men are dropping around the world may be wrong, according to a new study by University of Manchester, Queen’s University in Kingston, Canada and Cryos International, Denmark.
Researchers at Harvard University, Sabanci University, and Peking University recently gathered findings that could shed light on the origin of the high-temperature absorption peaks observed in strange metals, a class of materials exhibiting unusual electronic properties that do not conform to the conventional theory of metals.
In a development at the intersection of quantum mechanics and general relativity, researchers have made significant strides toward unraveling the mysteries of quantum gravity. This work sheds new light on future experiments that hold promise for resolving one of the most fundamental enigmas in modern physics: the reconciliation of Einstein’s theory of gravity with the principles of quantum mechanics.
A research team in China has initiated and successfully developed a jet origin identification technology which can significantly enhance the scientific discovery capabilities of high-energy collider experiments.
Researchers from the University of Colorado Anschutz Medical Campus have established a new framework for understanding how classic antidepressants work in treating major depressive disorder (MDD), reemphasizing their importance and aiming to reframe clinical conversation around their role in treatment.
Some children with autism experience profound, lifelong difficulties like developmental delay, social struggles and even the inability to speak. Others experience more mild symptoms that improve with time.
In what researchers have called an “unprecedented” response, a new drug that treats locally advanced rectal cancer has shown to have completely eradicated tumors in all 42 patients who took part in the Phase II trial.
The drug, Jemperli (dostarlimab-gxly), had earlier shown great potential for eliminating mismatch repair deficient (dMMR) cancers, which make up 5–10% of colorectal cancers. Following the Phase II trial, the first 24 patients assessed showed a “sustained complete clinical response” – no cancer evident – after an average of 26.3 months.
“These findings demonstrate the potential of dostarlimab-gxly as a novel approach to treating locally advanced dMMR rectal cancer that leads to durable complete tumor regression without the need for life-altering treatment,” said Dr Andrea Cercek, researcher and oncologist at the Memorial Sloan Kettering Cancer Center (MSK). “As a clinician, I’ve seen firsthand the debilitating impact of standard treatment of dMMR rectal cancer and am thrilled about the potential of dostarlimab-gxly in these patients.”
Basically confirmed whats been said here. AI will take over film making by 2029/2030.
Actor and entrepreneur Ashton Kutcher lauded OpenAI’s generative AI video tool Sora at a recent event. “I’ve been playing around with Sora, this latest thing that OpenAI launched that generates video,” Kutcher said. “I have a beta version of it, and it’s pretty amazing. Like, it’s pretty good.”
Continue reading “Actor and investor Ashton Kutcher Lauds OpenAI’s Video Model Sora” »
Prominent investor Ron Baron has come out in support of Tesla CEO Elon Musk’s $56 billion pay package, which is up for a shareholder vote next week, according to an open letter from the Baron Capital founder on Tuesday.
